940.F EUROAPI SAS EO 1

Healthcare Pharmaceuticals Frankfurt Exchange
0.7740 EUR
Close of Nov 11, 2026
0.7110 3.30
Market cap
EUR 73.9M
P/E
-
P/B
0.11x
ROE
-26.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 940.F undervalued?

Graham number

The Graham number of EUROAPI SAS EO 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EUROAPI SAS EO 1 fundamental analysis

No fundamental analysis for EUROAPI SAS EO 1 yet.

EUROAPI SAS EO 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EUROAPI SAS EO 1

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostag…

Full company profile